Translate
Aprea Therapeutics Inc
About
Aprea Therapeutics Inc (NASDAQ:APRE) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 1 2026
Aprea Therapeutics Announces Closing of Oversubscribed $30 Million Private Placement
Mar 30 2026
Aprea Therapeutics Announces Oversubscribed $30 Million Private Placement
Mar 16 2026
Aprea Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
Feb 18 2026
Aprea Therapeutics Announces Additional Positive Clinical Activity for WEE1 Inhibitor, APR-1051, Including Second Partial Response in Ongoing ACESOT-1051 Trial
Feb 17 2026
Aprea Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
Recent Videos
Comprar acciones de Aprea Therapeutics Inc: guía rápida (APRE)
Mar 18, 2026
01_29_26 Biotech Stock News. Daily Recap. #English #Shorts $XBI #trading #biotechnews #dailynews
Jan 29, 2026
Aprea Therapeutics, Inc. (APRE)
Jun 06, 2025
Aprea Therapeutics: Rollercoaster Ride of Cash, Costs, and Cures
Mar 26, 2025
Financials
Revenue
$285.76 K
Market Cap
$8.19 M
EPS
-1.93